Rare Medical News
Advertisement
Spotlight On
Infantile neuroaxonal dystrophy
Infantile neuroaxonal dystrophy is a type of lipid storage disorder that mostly affects the nervous system. It has two forms, a classic form and an atypical form.
Prevalence
unknown
N/A
US Estimated
N/A
Europe Estimated
Age of Onset
Infancy
ICD-10
G23.0
Inheritance Pattern
5 Facts you should know
FACT
Infantile neuroaxonal dystrophy (INAD) is a progressive, autosomal recessive neurodegenerative disorder most often caused by pathogenic variants in the PLA2G6 gene, leading to abnormal phospholipid metabolism and axonal spheroid formation
FACT
Onset usually occurs in the first 2 years of life with developmental regression, hypotonia, loss of motor milestones, and rapid progression to spasticity and profound neurologic disability
FACT
Ophthalmologic findings such as optic atrophy, nystagmus, and strabismus are common and often serve as early diagnostic clues alongside motor decline
FACT
Brain MRI typically demonstrates cerebellar atrophy, white matter changes, and iron accumulation in the globus pallidus and substantia nigra, features consistent with the neurodegeneration with brain iron accumulation (NBIA) spectrum
FACT
There is currently no curative treatment; management is supportive and multidisciplinary, including seizure control, physical therapy, nutritional support, and assistive care. Prognosis is poor, with many affected children not surviving beyond the first or second decade of life
Interest over time
Google searches
Common signs & symptoms
Developmental regression
Muscular hypotonia
Optic atrophy
Seizures
Loss of purposeful hand use
Neurodegeneration due to iron accumulation in the brain
Current treatments
Supportive and symptomatic care
Seizure management
Physical and occupational therapy
Nutritional support and mobility aids